AF
ABEO icon

Advisornet Financial’s Abeona Therapeutics ABEO Stock Holding History

Advisornet Financial’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-66
Closed -$2K – 1647
2020
Q3 		$2K Hold
66
– – ﹤0.01% 1540
2020
Q2 		$5K Hold
66
– – ﹤0.01% 1432
2020
Q1 		$3K Hold
66
– – ﹤0.01% 1501
2019
Q4 		$5K Sell
66
-4
-6% -$282 ﹤0.01% 1521
2019
Q3 		$4K Buy
70
+4
+6% +$300 ﹤0.01% 1580
2019
Q2 		$8K Hold
66
– – ﹤0.01% 1272
2019
Q1 		$12K Hold
66
– – ﹤0.01% 1118
2018
Q4 		$12K Buy
+66
New +$14.4K ﹤0.01% 1031

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisornet Financial's ABEO Position: Q4 2020 in Review

Advisornet Financial sold out of Abeona Therapeutics (ABEO) in Q4 2020, closing a stake of 66 shares — an estimated $2K sold.

Advisornet Financial first reported a position in ABEO in Q4 2018 and held it in 8 quarters. The position peaked at $12K in Q1 2019. 73 funds tracked by Wall St. Rank hold ABEO as of Q4 2020.

  • Advisornet Financial reported no remaining Abeona Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Advisornet Financial sold 66 Abeona Therapeutics shares in Q4 2020, an estimated $2K.
  • Advisornet Financial first reported a position in Abeona Therapeutics in Q4 2018 and held it in 8 quarters.
  • Advisornet Financial's Abeona Therapeutics position peaked at $12K in Q1 2019.
  • 73 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2020.

Based on Advisornet Financial's 13F filing for Q4 2020, filed 4 Feb 2021.